Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Major pharmaceutical companies reap most of their profits in the U.S. but shift their tax burdens to low-tax havens such as ...

Two European-headquartered drugmakers told Reuters this week they are sending as much of their medicines across the Atlantic ...

AscellaHealth has introduced its latest Specialty & Rare Pipeline Digest™, a quarterly publication designed to provide ...

India, China, and the European Union, which produce the vast majority of active pharmaceutical ingredients (APIs) used in ...

Tariffs are one way for Donald Trump to achieve tax cuts, and Irish-based pharma industry may be a golden goose ready for ...

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

Drugmakers are pushing back against pharmaceutical tariffs. Some companies are lobbying the Trump administration to phase in ...

H-E-B joins a lawsuit with Kroger, Albertsons and Walgreens to sue a pharmaceutical company for conspiring to delay the ...

Pfizer in 2019 sold $20 billion of drugs in the U.S. Its federal tax bill? Zero. That revelation was part of a Senate Finance ...

President Donald Trump is expected to announce sweeping tariffs on “all countries" affecting many industries, the likes of ...